Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
Showing page 290 |
first page | previous page | next page | last page |
Overall_Gscore | No. of Cancer Types | ||||
HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
IFNAR1 | ENSG00000142166 | 0.00 | 0.00 | 0 | 0 |
CSNK1G1 | ENSG00000169118 | 0.00 | 0.00 | 0 | 0 |
TDRD3 | ENSG00000083544 | 0.00 | 0.14 | 0 | 1 |
SLC9B1 | ENSG00000164037 | 0.00 | 0.00 | 0 | 0 |
ROCK1 | ENSG00000067900 | 0.00 | 0.00 | 0 | 0 |
TRPC4 | ENSG00000133107 | 0.00 | 0.00 | 0 | 0 |
ERP44 | ENSG00000023318 | 0.00 | 0.15 | 0 | 1 |
PSEN1 | ENSG00000080815 | 0.00 | 0.55 | 0 | 3 |
SLC29A3 | ENSG00000198246 | 0.00 | 0.00 | 0 | 0 |
IFNGR1 | ENSG00000027697 | 0.00 | 0.38 | 0 | 3 |
SCPEP1 | ENSG00000121064 | 0.00 | 0.00 | 0 | 0 |
SLC22A25 | ENSG00000196600 | 0.00 | 0.00 | 0 | 0 |
LIPA | ENSG00000107798 | 0.00 | 0.13 | 0 | 1 |
SLC27A1 | ENSG00000130304 | 0.00 | 0.00 | 0 | 0 |
TBK1 | ENSG00000183735 | 0.00 | 0.00 | 0 | 0 |
PIP4K2C | ENSG00000166908 | 0.00 | 0.00 | 0 | 0 |
VCPKMT | ENSG00000100483 | 0.12 | 0.00 | 1 | 0 |
PARP16 | ENSG00000138617 | 0.14 | 0.00 | 1 | 0 |
CPA1 | ENSG00000091704 | 0.00 | 0.00 | 0 | 0 |
HEXA | ENSG00000213614 | 0.00 | 0.00 | 0 | 0 |
Showing page 290 |
first page | previous page | next page | last page |